Nordnet Indexfond Europa vs UBS Lux Equity Fund Biotech USD

Nordnet Indexfond Europa vs UBS Lux Equity Fund Biotech USD

1. Nordnet Indexfond Europa

  • Security

    Nordnet Indexfond Europa ESG

  • Fee

    0.20%

  • ISIN

    IE00BMTD2L82

  • Holdings

    16

  • Number of owning funds

    3

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 25 holdings in Nordnet Indexfond Europa, where the largest holding is AstraZeneca (3.82), followed by Novo Nordisk (3.67) and HSBC Holdings (3.41). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.35) and Moderna (9.21).

All Holdings

Here we compare the holdings in Nordnet Indexfond Europa and UBS Lux Equity Fund Biotech USD.

Nordnet Indexfond Europa UBS Lux Equity Fund Biotech USD
1. AstraZeneca
Sweden UK
3.82 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Novo Nordisk ADR
Denmark
3.67 %
2. Vertex Pharmaceuticals Inc
9.35 %
3. HSBC Holdings PLC
UK
3.41 %
3. Moderna Inc
9.21 %
4. Unilever Plc
UK
2.71 %
4. Alnylam Pharmaceuticals Inc
6.96 %
5. TotalEnergies SE
France
2.16 %
5. AbbVie Inc
USA
5.53 %
6. Iberdrola SA
Spain
1.81 %
6. Gilead Sciences Inc
USA
4.66 %
7. RELX ADR
UK
1.74 %
7. Amgen Inc
4.3 %
8. Spotify Technology SA
Sweden
1.62 %
8. BioNTech SE
4.13 %
9. Muenchener Rueckversicherungs-Gesellschaft AG
Germany
1.57 %
9. Karuna Therapeutics Inc
3.75 %
10. Hermes International SCA
France
1.48 %
10. Royalty Pharma Plc
3.37 %
11. AXA SA
France
1.44 %
-
12. ABB Ltd
Sweden Switzerland
1.43 %
-
13. Intesa Sanpaolo SpA
Italy
1.38 %
-
14. National Grid Plc
UK
1.22 %
-
15. Enel SpA
1.21 %
-
16. Prosus NV
Netherlands
1.09 %
-

The list of fund holdings was last updated on June 5, 2025.